News | RIVM

Vaccination against meningococcal disease starts for teens aged 14 to 18

This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.

Vaccination schedule for babies reviewed after introduction whooping cough vaccination for pregnant women

Whooping cough is a dangerous disease for new born, unvaccinated babies. Starting at the end of 2019, the whooping cough vaccination will be offered nationwide to pregnant women.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Teen vaccination against meningococcal disease starts

From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

Outbreak of avian influenza A (H5N8) in Dutch poultry

In November 2014 avian ‘flu has been detected on poultry farms in the Netherlands.

The National Immunisation Programme in the Netherlands 2013 - 2014

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

Increasing number of girls immunised against HPV

In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.

The National Immunisation Programme in the Netherlands: Developments in 2013

Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).